Analysts at StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a research note issued on Saturday. The firm set a “hold” rating on the biopharmaceutical company’s stock.
Athersys Price Performance
The stock has a market capitalization of $833,000.00, a PE ratio of 0.00 and a beta of -0.90. Athersys has a 12-month low of $0.01 and a 12-month high of $1.99.
Athersys Company Profile
Featured Stories
- Five stocks we like better than Athersys
- What to Know About Investing in Penny Stocks
- FedEx Delivers Another Crushing Blow to Its Stock Price
- What Are Trending Stocks? Trending Stocks Explained
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- Stock Market Sectors: What Are They and How Many Are There?
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
